Anton Hagenbeek, MD, PhD is a Professor of Hematology in the Academic Medical Center, University of Amsterdam, The Netherlands
Prof. Hagenbeek received his medical degree from the Erasmus University, Rotterdam, The Netherlands, and trained in experimental hematology at the Radiobiological Institute TNO in Rijswijk, The Netherlands, where he obtained his PhD in 1977. After receiving further training in internal medicine/hematology from the Erasmus University, he obtained a fellowship in hematology at the University of California, Los Angeles (UCLA), US.
Speaking on Lymphoma trials, treatment and research
Prof. Hagenbeek is officially retired but retains special appointment as a professor and is mainly focusing on running clinical trials for the Lunenburg Lymphoma Biomarker Consortium (LLBC)/ Lunenburg Lymphoma Phase I/II Consortium (LLPC). He is also on the advisory board of a number of hemato-oncology journals and congresses and is heading up communication meetings and press briefings at the EHA.